# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 605 results.
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Nov 25, 2019
First Received: Nov 25, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): Bevacizumab, Tocotrienol
Locations: Department of Oncology, Vejle Hospital, Vejle, Denmark
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Aug 01, 2017
First Received: Aug 01, 2017
Disease(s): Ovarian Cancer
Intervention(s): cardiophrenic lymph nodes resection
Locations: Oncology center, Mansoura University, Cairo, Dakhlia, Egypt
Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jul 23, 2018
First Received: Jul 23, 2018
Disease(s): Ovarian Cancer
Intervention(s): Pembrolizumab, Bevacizumab, pegylated liposomal doxorubicin (PLD)
Locations: Gustave Roussy, Villejuif, Val De Marne, France
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer
Status: Recruiting
Last Changed: Sep 18, 2019
First Received: May 02, 2016
Disease(s): Ovarian Cancer
Locations: Tampere University Hospital, Tampere, Finland
Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Feb 21, 2020
First Received: Aug 28, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): Tumor Infiltrating Lymphocytes (TIL), Interferon Alfa 2A, Carboplatin, Paclitaxel
Locations: Leiden University Medical Center, Leiden, ZH, Netherlands
A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
Status: Recruiting
Last Changed: Mar 19, 2020
First Received: Oct 04, 2018
Disease(s): OVARIAN CANCER
Intervention(s): Cobimetinib, Niraparib, Atezolizumab
Locations: University of Arizona Cancer Center, North, Tucson, Arizona, United States
Moores Cancer Center at UC San Diego Health, La Jolla, California, United States
Sutter Health, San Francisco, California, United States
Mayo Clinic-Jacksonville, Jacksonville, Florida, United States
Florida Hospital Cancer Institute; Clinical Research Department, Orlando, Florida, United States
... and 25 other locations.
Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer
Status: Recruiting
Last Changed: Mar 06, 2020
First Received: Jan 23, 2017
Disease(s): Ovarian Cancer
Intervention(s): Vitamin D3
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
Status: Recruiting
Last Changed: Dec 04, 2018
First Received: Dec 04, 2018
Disease(s): Ovarian Cancer
Intervention(s): Sevacizumab, Paclitaxel, Topotecan
Locations: Beijing Cancer Hospital, Beijing, Beijing, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
The first affiliated hospital,sun yat-sen university, Guangzhou, Guangdong, China
the Affiliated Cancer Hospital of Harbin Medical University, Harbin, Hei Longjiang, China
Hunan Cancer Hospital, Changsha, Hunan, China
... and 2 other locations.
Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125
Status: Recruiting
Last Changed: Oct 01, 2019
First Received: Dec 28, 2016
Disease(s): Ovarian Cancer
Locations: Department of Oncology, Vejle Hospital, Vejle, Denmark
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
Status: Recruiting
Last Changed: Aug 29, 2019
First Received: Jun 08, 2017
Disease(s): Ovarian Cancer
Intervention(s): OTL38, near infrared imaging
Locations: The Mayo Clinic - Phoenix, Phoenix, Arizona, United States
University of Arizona, Tucson, Arizona, United States
City of Hope Medical Center, Duarte, California, United States
University of CA at Irvine Chao Cancer Center, Orange, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
... and 8 other locations.